Matches in SemOpenAlex for { <https://semopenalex.org/work/W3000872178> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- W3000872178 endingPage "13" @default.
- W3000872178 startingPage "8" @default.
- W3000872178 abstract "Context: Endometrial cancer is a frequently encountered gynecological malignancy. An adverse prognostic immunohistochemical marker had not been identified until recently. Recent studies have used human epidermal growth factor receptor 2 (HER2)/neu expression as a marker for adverse outcomes in carcinoma endometrium, as proven in carcinoma breast. Aim: The present study was undertaken to correlate HER2/neu expression with prognostic factors in cases of endometrial carcinoma. Materials and Methods: This was a prospective study on evaluation of HER2/neu expression done on 30 patients with biopsy-proven carcinoma endometrium admitted in the hospital for staging laparotomy. Histopathological examination was performed and HER2/neu expression was assessed by immunohistochemistry and was categorized into (1) Group 1: HER2/neu 0/1+ (negative), (2) Group 2: HER2/neu 2+ (equivocal), and (3) Group 3: HER2/neu 3+ (positive). All the cases were followed up for a period of 1 year. Statistical Analysis: All data analyses were carried out using statistical software SPSS, IBM version 21.0. P < 0.05 was considered as significant. Results: 0/1+ HER2/neu expression (negative) was detected in 19 patients (63.33%), 2+ HER2/neu expression (equivocal) was detected in 4 patients (13.33%), and 3+ HER2/neu expression (positive) was detected in 7 patients (23.33%). HER2/neu 3+ group was significantly associated with non-endometrioid histology ( P = 0.003) and high tumor grade ( P = 0.005). The association of HER2/neu 3+ group with advanced disease and lymph node involvement showed a trend, but it was not statistically significant. No association was found between HER2/neu overexpression and extent of myometrial invasion. There were two recurrences in 1 year follow-up period. HER2/ neu expression (2+ and 3+) was seen the recurrence cases. Conclusion: HER2/neu overexpression was found to be an adverse prognostic marker in carcinoma endometrium, which could form the basis of targeted chemotherapy." @default.
- W3000872178 created "2020-01-30" @default.
- W3000872178 creator A5012188202 @default.
- W3000872178 creator A5021886519 @default.
- W3000872178 creator A5022590555 @default.
- W3000872178 creator A5023235547 @default.
- W3000872178 creator A5029219579 @default.
- W3000872178 creator A5040773022 @default.
- W3000872178 creator A5087422498 @default.
- W3000872178 date "2020-01-21" @default.
- W3000872178 modified "2023-09-23" @default.
- W3000872178 title "Evaluation of prevalence and prognostic significance of human epidermal growth factor receptor 2/neu expression in carcinoma endometrium" @default.
- W3000872178 cites W1492415140 @default.
- W3000872178 cites W1664049038 @default.
- W3000872178 cites W1982252613 @default.
- W3000872178 cites W1986840948 @default.
- W3000872178 cites W1990722281 @default.
- W3000872178 cites W2012768356 @default.
- W3000872178 cites W2018958804 @default.
- W3000872178 cites W2025731174 @default.
- W3000872178 cites W2050470545 @default.
- W3000872178 cites W2063258398 @default.
- W3000872178 cites W2069451423 @default.
- W3000872178 cites W2085749401 @default.
- W3000872178 cites W2128201398 @default.
- W3000872178 cites W2768465737 @default.
- W3000872178 cites W2806209829 @default.
- W3000872178 cites W2915720971 @default.
- W3000872178 doi "https://doi.org/10.25259/ijmio_20_2019" @default.
- W3000872178 hasPublicationYear "2020" @default.
- W3000872178 type Work @default.
- W3000872178 sameAs 3000872178 @default.
- W3000872178 citedByCount "2" @default.
- W3000872178 countsByYear W30008721782022 @default.
- W3000872178 crossrefType "journal-article" @default.
- W3000872178 hasAuthorship W3000872178A5012188202 @default.
- W3000872178 hasAuthorship W3000872178A5021886519 @default.
- W3000872178 hasAuthorship W3000872178A5022590555 @default.
- W3000872178 hasAuthorship W3000872178A5023235547 @default.
- W3000872178 hasAuthorship W3000872178A5029219579 @default.
- W3000872178 hasAuthorship W3000872178A5040773022 @default.
- W3000872178 hasAuthorship W3000872178A5087422498 @default.
- W3000872178 hasBestOaLocation W30008721781 @default.
- W3000872178 hasConcept C121608353 @default.
- W3000872178 hasConcept C126322002 @default.
- W3000872178 hasConcept C142724271 @default.
- W3000872178 hasConcept C143998085 @default.
- W3000872178 hasConcept C204232928 @default.
- W3000872178 hasConcept C2776872082 @default.
- W3000872178 hasConcept C2777546739 @default.
- W3000872178 hasConcept C2779399171 @default.
- W3000872178 hasConcept C2780849966 @default.
- W3000872178 hasConcept C29456083 @default.
- W3000872178 hasConcept C3018521938 @default.
- W3000872178 hasConcept C530470458 @default.
- W3000872178 hasConcept C71924100 @default.
- W3000872178 hasConceptScore W3000872178C121608353 @default.
- W3000872178 hasConceptScore W3000872178C126322002 @default.
- W3000872178 hasConceptScore W3000872178C142724271 @default.
- W3000872178 hasConceptScore W3000872178C143998085 @default.
- W3000872178 hasConceptScore W3000872178C204232928 @default.
- W3000872178 hasConceptScore W3000872178C2776872082 @default.
- W3000872178 hasConceptScore W3000872178C2777546739 @default.
- W3000872178 hasConceptScore W3000872178C2779399171 @default.
- W3000872178 hasConceptScore W3000872178C2780849966 @default.
- W3000872178 hasConceptScore W3000872178C29456083 @default.
- W3000872178 hasConceptScore W3000872178C3018521938 @default.
- W3000872178 hasConceptScore W3000872178C530470458 @default.
- W3000872178 hasConceptScore W3000872178C71924100 @default.
- W3000872178 hasLocation W30008721781 @default.
- W3000872178 hasOpenAccess W3000872178 @default.
- W3000872178 hasPrimaryLocation W30008721781 @default.
- W3000872178 hasRelatedWork W2053551177 @default.
- W3000872178 hasRelatedWork W2061929337 @default.
- W3000872178 hasRelatedWork W2327662849 @default.
- W3000872178 hasRelatedWork W2338318399 @default.
- W3000872178 hasRelatedWork W2385139574 @default.
- W3000872178 hasRelatedWork W2394139590 @default.
- W3000872178 hasRelatedWork W2443284480 @default.
- W3000872178 hasRelatedWork W2460251460 @default.
- W3000872178 hasRelatedWork W2472936265 @default.
- W3000872178 hasRelatedWork W4286462803 @default.
- W3000872178 hasVolume "5" @default.
- W3000872178 isParatext "false" @default.
- W3000872178 isRetracted "false" @default.
- W3000872178 magId "3000872178" @default.
- W3000872178 workType "article" @default.